Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms

Pharmiweb.com RSS Feed Pharmiweb.com RSS Feeds

Pharmiweb.com RSS Feed PharmiWeb Candidate Blog

Pharmiweb.com RSS Feed PharmiWeb Client Blog

Advertising

Press Release

PerkinElmer Elects Samuel Chapin to Board of Directors

PerkinElmer,Inc.
Posted on: 17 Oct 16

PerkinElmer, Inc., (NYSE:PKI) a global leader committed to innovating for a healthier world, today announced that Samuel R. Chapin has been elected to the Company’s Board of Directors.

"I am pleased to welcome Samuel to our Board, as he brings extensive experience in strategic advisory, mergers and acquisitions, and deal financing for a wide range of transactions, along with deep knowledge of the industrial marketplace,” said Robert Friel, Chairman and Chief Executive Officer, PerkinElmer.

Chapin most recently served as Executive Vice Chairman of Global Corporate & Investment Banking for Bank of America Merrill Lynch, where he held the role since 2010 and was responsible for managing relationships with the firm's largest clients. He retired as of June 30, 2016.

Chapin was named Vice Chairman of Merrill Lynch & Co in September 2003 and was a member of the firm's executive Operating Committee. From 2001 to 2003, he was Senior Vice President and Head of the Global Investment Banking division. He previously led the investment banking group that covered industrial companies, actively managing the firm's relationships with clients in the industrial, resources and consumer products industries. He joined Merrill Lynch in 1984 as a member of the Mergers & Acquisitions group and was named a managing director in Corporate Banking in 1993. He has worked on a wide range of financings and strategic advisory assignments totaling over $500 billion. Chapin has also been named Investment Banker of the year by Investment Dealers' Digest.

Chapin received a Bachelor of Arts from Lafayette College and a Master of Business Administration, with distinction, from The Wharton School at the University of Pennsylvania. He also serves on the board of trustees at Lafayette College and is a director for the Wharton Financial Advisory Board. Chapin is also a member of the board of directors of the Roundabout Theatre Company.

About PerkinElmer, Inc.

PerkinElmer, Inc. is a global leader committed to innovating for a healthier world. The Company reported revenue of approximately $2.3 billion in 2015, has approximately 8,000 employees serving customers in more than 150 countries, and is a component of the S&P 500 Index. Additional information is available through 1-877-PKI-NYSE or at www.perkinelmer.com.

View source version on businesswire.com: http://www.businesswire.com/news/home/20161017005299/en/

Business Wire
www.businesswire.com

Last updated on: 17/10/2016

Advertising
Share | | |
Site Map | Privacy & Security | Cookies | Terms and Conditions

PharmiWeb.com is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on PharmiWeb.com is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.